Ongoing projects

?

Sl No

Title

Granting agency

Principal investigator

1

Application of autozygosity mapping and exome sequencing to identify genetic basis of disorders of skeletal development

Science & Engineering 沙巴体育 Board, New Delhi

Dr Girisha K M

2

The Mechanism and Clinical Profile of Steroid induced diabetes

沙巴体育 Society for the study of Diabetes in India (RSSDI)

Dr Sudha Vidyasagar

3

Assessment of the expression of bacterial proteins and its correlation with the clinical presentations of acute and chronic form of brucellosis

Defence R & D Establishment, Gwalior

Dr Chiranjay Mukhopadhyay

4

Fertility prevention in cancer affected prepubertal boys: an experimental approach using testicular tissue cryopreservation

Indian Council of Medical 沙巴体育, New Delhi

Dr Satish Kumar Adiga

5

Multicentric Collaborative study of the Clinical Biochemical and Molecular Characterization by Lysosomal Storage Disorders in India - The initiative for research in LSD

Indian Council of Medical 沙巴体育, New Delhi

Dr Girisha K M

6

Clinical and Molecular Characterization of Leukodystrophies in India Children

Indian Council of Medical 沙巴体育, New Delhi

Dr Anju Shukla

7

Development and validation of an electronic surveillance system for surgical site infections developing during hospital stay and after discharge: A Multi-centric study

All India Institute of Medical Sciences, New Delhi

Dr Chiranjay Mukhopadhyay

8

Baseline/End line survey

National Tobacco Control Programme, Udupi

Dr Muralidhar M Kulkarni, Department of Community Medicine

9

Teachers Associateship for 沙巴体育 Excellence (TARE) (Health Sciences)

SERB, New delhi

Dr Prasanna LC

10

Designing liposome based freezing medium for testicular tissue cryopreservation to aid in male fertility preservation

Indian Council of Medical 沙巴体育, New Delhi

Dr Guruprasad Kalthur

11

Improving the clinical care of children and young adults with marfan syndrome and related disorders by molecular genetic testing through next generation sequencing

ICMR, New Delhi

Dr Girisha K M

12

Prevalence of cognitive dysfunction in type 2 diabetes mellitus patients in India population and understanding their possible link through targeted lipidomics approach

RSSDI, New Delhi

Dr Mukhyaprana Prabhu

13

Association bewteen serum osteocalcin and metabolic syndrome: A cross sectional study

RSSDI, New Delhi

Dr Sudha Vidyasagar

14

Investigating the role of IFT52 and EXOC6B in human biology and disease using cell-culture and Drosophila systems

SERB, New Delhi

Dr Priyanka Upadhyai

15

Pilot study to observe the effect of “soap puva” therapy in treatment of psoriasis

IADVL, Academy Bangalore

Dr Satish Pai B

16

Fever, Hyperglycemia, Swallowing and Hypertension Management in Acute Stroke: A Cluster Randomized Trial (Indian Quality Improvement in Stroke Care Study) under "Indian Stroke 沙巴体育 Network"

All India Institute of Medical Sciences, New Delhi

Dr (Brig) Sankar Prasad, Neurology

17

Effect of maternal exposure of metformin on fetal gonadal development and their reproductive potential

SERB, New Delhi

Dr Guruprasad Kalthur

18

Liquid Biopsy Strategies for early detection and treatment monitoring of Human Papilloma Virus (HPV) associated cancers in India

DBT, New Delhi

Dr Rama Rao Damerla

19

Socio-Cultural and environmental drivers of antibiotic resistance in the community, People, Physicians and pharmacist’s perspective a mixed methods approach

ICMR, New Delhi

Dr Chythra R Rao

20

Registry of people with Diabetes in India with Young Age at Onset -II

ICMR, New Delhi

Dr Sudha Vidyasagar

21

Population Pharmacokinetic and Pharmacodynamic study of Caffeine and Aminophylline in Apnea of prematurity

SERB, New Delhi

Dr Leslie Edward Lewis

22

Impact of maternal diabetes on pre-implantation embryo development: Non-invasive approach to assess embryo quality using oxygen consumption

SERB, New Delhi

Dr Satish Kumar Adiga

23

Fertility prevention in cancer affected prepubertal boys: an experimental approach using testicular tissue cryopreservation

ICMR, New Delhi

Dr Satish Kumar Adiga

24

Purse Full time Doctoral (Ph.D.) Program under the AORC scheme of the Inspire Program of the DST, New Delhi

DST, New Delhi

Ms Suomi Chowdhury, under Dr. Chiranjay Mukhopadhyay

25

Impact of embryological interventions on functional, genetic and epigenetic integrity of gametes and embryos in ART

ICMR, New Delhi

Dr Satish Kumar Adiga

26

Initiating Antimicrobial Stewardship activities in hospitals in India

ICMR, New Delhi

Dr Muralidhar Varma

27

Capacity building and strengthening of Hospital Infection Control to Detect and Prevent Antimicrobial Resistance in India

JPN Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi

Dr Chiranjay Mukhopadhyay

28

Regional Center for Antimicrobial Resistance Surveillance Network

ICMR, New Delhi

Dr Chiranjay Mukhopadhyay

29

Fever, Hyperglycemia, Swallowing and Hypertension Management in Acute Stroke: A Cluster Randomized Trial (Indian Quality Improvement in Stroke Care Study) under "Indian Stroke 沙巴体育 Network"

All India Institute of Medical Sciences, New Delhi

Dr (Brig) Sankar Prasad, Neurology

30

Deciphering the biological role of the three-mammalian eukaryotic Initiation Factor 4 Binding Proteins (4E-BPs) against a null background of their paralogues with the goal to identify their activators and repressors as potential therapeutic targets in neuroinflammatory disorders such as Parkinson's and astrocytomas, which is a cancer in the CNS

DBT, New Delhi

Dr. Somasish Ghosh Dastidar

31

Identification of epigenetic, Transcriptional and behavioral mechanisms engaged by schizophrenia and related neuropsychiatric disorders using Drosophila as a Model

DBT, New Delhi

Dr Pawan Kumar Agarwal

32

Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package in India (SPRINT)_INDIA)

ICMR, New Delhi

Dr Sankar Prasad Gorthi, Neurology

33

Comparison analysis of various diagnostic tools to resolve the diagnostic dilemma in Leptospirosis

ICMR, New Delhi

Dr Shashidhar V

34

Registry of people with Diabetes in India with Young Age at Onset -II

Indian Council of Medical 沙巴体育, New Delhi

Dr Sudha Vidyasagar

35

Anti-Inflammatory exosomes: Potential drug delivery system to ocular diseases

DBT, New Delhi

Dr Dinesh Upadhya

36

To carry out iodine Deficiency Disorders (IDD) Survey

District Surveillance Officer, Udupi

Dr Suma Nair

37

Enhancement of Detection of Pediatric TB cases (≤15 years) in Udupi TU after strengthening the skills of health care workers to perform induced sputum production

District Tuberculosis Control Office, Udupi

Dr Kiran Chawla

38

Clinical Phenotypes and genetic regulation of endometriosis in Indian women

ICMR- National Institute for 沙巴体育 Reproductive Health, Mumbai

Dr Muralidhar V Pai

? ? ? ? ?

?

?

Private/Industry grant

?

Sl No

Title

Source

Principal investigator

1

Compliance Assessment Survey of Section 4 of COTPA-2003 in Kalaburagi District of Karnataka State

The Office of the District survelience & Programme Officer, National tobacco Control Programme, Department of Health, Govt. of Karnataka, Kalaburagi

Dr Thippeswamy V, Department of Psychiatry

2

Variations in Default Mode Network of Brain Among Rajayoga Meditators, Non-Meditators and Patients with Migraine Disorder _ An In-depth Voxel Based Morphometric Analytical Study of sMRI and fMRI

Rajyoga Education and 沙巴体育 Foundation

Dr K V Rajagopal MD, Department of Radiodiagnosis and Imaging

3

Baseline/End line survey

National Tobacco Control Programme, Udupi

Dr Muralidhar M Kulkarni, Department of Community Medicine

4

沙巴体育 Plan for Software Design Language System for India

Philips India Ltd, Bangalore

Dr Suma Nair, Dept of Community Medicine, KMC, 沙巴体育

5

沙巴体育 Plan for Clinical Study of Non-contact monitoring of Respiratory Rate & Hart Rate in Non-acuity settings

Philips India Ltd, Bangalore

Dr Trevor Sequeira

6

Specific 沙巴体育 Plan for Anatomical Classification of ultrasound images for workflow optimization data collection study phase 3 project

Philips India Ltd, Bangalore

Dr Rajgopal K V, KMC, 沙巴体育

7

沙巴体育 Plan for Scorecard for Inborn Error of Metabolism

Philips India Ltd, Bangalore

Dr Leslie Lewis, KMC, 沙巴体育

8

Training of Embryology under Merck Asset Program for the year 2018

Merck Specialities Pvt Ltd

Dr Satish Kumar Adiga

9

Prevalence and Genotype Distribution of Hapatitis and e virus infection in healthy voluntary blood donors and TPL agrees to support KMC in its study efforts

Terumo Penpol Pvt Ltd

Dr Shamee Shastry

10

The Prevalence Study of Specific Micronutrient Deficiencies in School Going Children Aged Between 6-16 Years in Ten Cities of India.

King George's Medical University, Lucknow

Dr Suma Nair

11

Specific 沙巴体育 Plan for Machine learning tool for diagnosis & staging of laryngeal cancer using CT scan Project

Philips India Ltd, Bangalore

Dr Rohit Singh, Dept of ENT, KMC, 沙巴体育

12

沙巴体育 Plan for Clinical Study of Non-contact monitoring of Respiratory Rate & Hart Rate in Non-acuity settings

Philips India Ltd, Bangalore

Dr Trevor Sequeira

13

Specific 沙巴体育 Paln for Pilot Study for development of a Data Analytics Model for Determining the prognostic Factors of Head & Neck Cancer

Philips India Ltd, Bangalore

Dr Krishna Sharan, Dept of Radiotherapy & Oncology, KMC, 沙巴体育

14

A Prospective study of correlation of acetylcholine receptor antibody titers with clinical activity in pemphigus disease

IADVL, Academy Bangalore

Dr Anuradha Jindal

15

Serum Osteocalcin and Parameters of Glucose Metabolism in type 2 Diabetes Mellitus

RSSDI, New Delhi

Dr Sudha Vidyasagar

16

A comparative study of sperm viability and DNA fragmentation analysis in rapid pre-stained slides, Eosine-Nigrosine staining, Tunel and SCD

Sar Healthline Private Limited

Dr Satish Kumar Adiga

17

Artificial intelligence Enabled Acute Ischemic Strokes infracts Volume Estimation, Intracranial Emergent large vessel occlusions quantification

Philips India Ltd, Bangalore

Dr S P Gorthi, Dept of Neurology, KMC, 沙巴体育

18

Microbiological & Molecular Characterization of Clostridium difficile isolates

Central India Institute of Medical Sciences, Nagpur (CIIMS)

Dr Padmaja A Shenoy

19

Pathogenicity, resistance attributes and clinical impact of Acinetobactor baumannli compels infections in ICU settings to understand challenges and opportunities for prevention

Lady Tata Memorial Trust

Ms Mansa Tantry Guide - Dr Vandana K E

20

The Prevalence Study of Specific Micronutrient Deficiencies in School Going Children Aged Between 6-16 Years In Ten Cities of India.

King George's Medical University, Lucknow

Dr Suma Nair

21

Analysis of Intracranial hemorrhage detection Models using Non-Vontrast Head CT

Philips India Ltd, Bangalore

Dr Rajgopal K V

?

?

Clinical Trials

?

1

EX9536-4388

Novo Nordisk India Private Limited

Dr Padma Kumar

2

SH600003

Shantha Biotechnics Private Limited

Dr Ranjitha Shetty, Department of Community Medicine

3

GS-US-418-4279

Klinera Corporation India

Dr Ganesh Pai

4

Tips-3

St.John's 沙巴体育 Institute

Dr Sudha Vidyasagar

5

EX2211-3748

Novo Nordisk India Pvt Ltd

Dr Sudha Vidyasagar

6

SRPL-OA-16-17

Ecron Acunova Limited

Dr Vivek Pandey

7

GS-US-418-3898

KlinEra Corporation India, Mumbai

Dr Ganesh Pai

8

CACZ885M2301

Novartis Healthcare Pvt Ltd

Dr Tom Devasia

9

CLCZ696D2302

Novartis Healthcare Pvt Ltd

Dr Tom Devasia

10

SII-qHPV/IN-02

Serum Institue of India Pvt Ltd

Dr Veena Kamath

11

63623872FLZ3001

IQVIA RDS (India) Private Limited

Dr Muralidhar Varma

12

Protocol No. 0329-17 A Single arm,Multicentric, Open label Efficacy and safety study of docetaxel lipid suspension for injection of intas pharmaceuticals limited, india in patients with metastatic castration resistant prostate cancer

Lambda Therapeutic 沙巴体育 Ltd

Dr Padmaraj Hegde

13

Protocol A5481037

Parexel 沙巴体育 Clinical 沙巴体育 Private Limited

Dr Donald Fernandes

14

Protocol No NOPRODSCH4001: An observational study for schizophrenia relapse prediction

IQVIA RDS(India)Pvt Ltd

Dr PSVN Sharma

15

Protocol No.00320 & Project code: XYA35263 title" A randomized, controlled, assessor-blind, parallel groups, multicenter trial in India comparing the efficacy and safety of FE 999049 (follitropin delta) with follitriopin alfa (GONAL-F) in controlled ovarian stimulation in women undergoing an assisted reproductive technology programme (Ferring Pharmaceuticals A/S/ 000320)”

IQVIA RDS(India)Pvt Ltd

Dr Pratap Kumar, OBG

16

Protocol 63623872FLZ3002:? A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination with the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects with Influenza an Infection who Are at Risk of Developing Complications?

IQVIA RDS(India)Pvt Ltd

Dr Muralidhar Varma

17

Protocol A5481037

Parexel 沙巴体育 Clinical 沙巴体育 Private Limited

Dr Donald Fernandes

18

SII-qHPV/IN-02

Serum Institue of India Pvt Ltd

Dr Veena Kamath

19

Protocol No NOPRODSCH4001: An observational study for schizophrenia relapse prediction

IQVIA RDS(India)Pvt Ltd

Dr PSVN Sharma

20

Protocol No. R092670PSY3015 title" A Double -blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation

Johnson & Johnson Pvt Ltd

Dr PSVN Sharma

21

Immune Lot-to-Lot Consistency and Non-Inferiority of SHAN6tm Vaccine Comparison to SHAN 5 + SHANIPV When Administred as Three Doses at 6-8, 10-12 and 14-16 weeks of age in Health Indian Infants, Concomitantly with Oral Rotavirus Vaccine

Shantha Biotechnic Pvt Ltd

Dr Ranjitha Shetty

22

GPL/CT/2016/009/III

Glenmark Pharmaceuticals Ltd

Dr Sudha Vidyasagar

23

SII-qHPV/IN-02

Serum Institue of India Pvt Ltd

Dr Veena Kamath

24

GENA-05

JSS Medical 沙巴体育 India Private Limited

Dr Dinesh Nayak

25

Protocol No.RI-01-006 "A Randomised Double-blind, Parallel-group, Phase III study to Compare the efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) with MabThera in Subjects with Previously Untreated Stage II-IV Cluster of Differentiation (CD) 20-Positive Low Tumour Burden Follicular Lymphoma

Parexel 沙巴体育 Clinical 沙巴体育 Pvt Ltd

Dr Karthik S Udupa

26

EX9536-4388

Novo Nordisk India Private Limited

Dr Padma Kumar

27

SRPL-OA-16-17

Ecron Acunova Limited

Dr Vivek Pandey

28

EX9536-4388

Novo Nordisk India Private Limited

Dr Padma Kumar

29

Accuracy of 3D surface rendering of 2D ultrasound images of uterus in mapping of uterine fibroids

Nesa Medtech Pvt Ltd

Dr Shyamala G, OBG, KMC

30

Protocol A5481037

Parexel 沙巴体育 Clinical 沙巴体育 Private Limited

Dr Donald Fernandes

31

CACZ885M2301

Novartis Healthcare Pvt Ltd

Dr Tom Devasia

32

SII-qHPV/IN-02

Serum Institute of India Pvt Ltd

Dr Veena G Kamath

33

CLCZ696D2302

Novartis Healthcare Pvt Ltd

Dr Tom Devasia

34

SLE-BRAVE-11 (14V-MC-JAIA)

PPD Pharmaceuticals Development India Pvt Ltd

Dr Mukhyaparana Prabhu

35

Protocol No.: GS-US-418-3898: "Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis".

KlinEra Corporation India, Mumbai

Dr Ganesh Pai

36

GS-US-418-4279

Klinera Corporation India

Dr Ganesh Pai

37

Protocol No. R092670PSY3015 title" A Double -blind,Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation

Johnson & Johnson Pvt Ltd

Dr PSVN Sharma

38

Protocol A5481037

Parexel 沙巴体育 Clinical 沙巴体育 Private Limited

Dr Donald Fernandes

39

Tips-3

St.John's 沙巴体育 Institute

Dr Sudha Vidyasagar

40

GENA-05

JSS Medical 沙巴体育 India Private Limited

Dr Dinesh Nayak

41

Intravenous Treatment for scrub Typhus (INTREST Trial)

Christian Medical College, Vellore

Dr Kavitha Saravu

42

CLCZ696D2302

Novartis Healthcare Pvt Ltd

Dr Tom Devasia

43

Protocol: CACZ885M2301

Novartis Healthcare Pvt Ltd

Dr Tom Devasia

44

Immune Lot-to-Lot Consistency and Non-Inferiority of SHAN6tm Vaccine Comparison to SHAN 5 + SHANIPV When Administred as Three Doses at 6-8, 10-12 and 14-16 weeks of age in Helath Indian Infants, Concomitantly with Oral Rotavirus Vaccine

Shantha Biotechnics Pvt Ltd

Dr. Ranjitha Shetty

45

Protocol No. SII-wHEXA/IN-02 - An Open Label, Randomized, Active-controlled, Multi-centric phase II/III study in Indian Toddlers and infants to assess the Immunogenicity and Safety of SIIPL HEXASIIL tm (DTwP-HepB-IPV-Hib) Vaccine in Comparison to SIIPL Pentavac (DTwP-HepB-HiB) + Poliovac (IPV) Vaccines in Administered as Separate injections

DiagnoSearchLife Sciences Pvt Ltd

Dr Veena G Kamath

46

Study Number: CTQJ230A12001 Multi-Centre Cross- Sectional Epidemiological study to characterize the prevalence and distribution of lipoprotein(A) Evels among patients with established cardiovascular disease

Novartis Healthcare Private Limited

Dr Tom Devasia

47

Protocol No.RI-01-006 "A Randomized Double-blind, Parallel-group, Phase III study to Compare the efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) with MabThera in Subjects with Previously Untreated Stage II-IV Cluster of Differentiation (CD) 20-Positive Low Tumour Burden Follicular Lymphoma

Parexel 沙巴体育 Clinical 沙巴体育 Pvt Ltd

Dr Karthik S Udupa

48

Protocol No TX05-03 title" A randomized, double-blind, parallel group, Phase III trial to compare the efficacy, safety, and immunogenicity of TX05 with Herception in subjects with HER2 positive early breast cancer

JSS Medical 沙巴体育 India Private Limited

Dr Krishna Sharan

?

?

Foreign grants

?

Sl No

Title

Source

Principal Investigator

1

Characterization of diff. in the gut microbiome composition & function b/w cohorts of south east Asians, immigrants and 1st generation Indo-Canadians

University of British Columbia

Dr Mamatha Ballal

2

Identifying the enteropathogenic E coli isolated from adults & children suffering from acute gastroenteritis in 沙巴体育ern India

University of Hong Kong

Dr Mamatha Ballal

3

Towards collaborative grant for process optimization of Molecular oligochromatograpy

University of Cambridge

Dr Mamatha Ballal

4

Capacity building for cancer & palliative care at the Kasturba Medical College, 沙巴体育

Jiv Daya Foundation

Dr Naveen Salins

5

Travel Grant- SRF

Society for reproduction & Fertil, UK

Dr Guruprasad Kalthur/Sandhya kumari

6

MARS India-observation study in KMC, 沙巴体育

AMC Medical research B V, Netherland

Dr Chiranjay Mukhopadhyay

7

Stigma as a barrier to cancer palliative care outcomes among people with HIV in India

University of California San Francisco (NIH)

Dr Naveen Salins

8

Primary prevention of chronic lung disease in India: preventing smoking uptake among adolescents

University of Nottingham

Dr Muralidhar M K

9

Building capacity for applied research to reduce tobacco-related harm in low- & middle-income countries.

University of Stirling

Dr Muralidhar M K

10

Project – to provide a Palliative Care Training program aimed at developing Palliative Care services and making morphine supplies available at Cancer Treatment Centres (CTCs) in India

APHN-CTC

Dr Naveen Salins

11

Collaborative Grant for Molecular differentiation of pandemic & non-pandemic V. cholerae

University of Cambridge

Dr Mamatha Ballal

12

Gazelle Malaria Clinical Accuracy Study

Hemex Health Inc

Dr Kavitha Saravu

13

Case Studies of Successful FAIMER Fellows using Success Case Method

FAIMER, USA

Dr Animesh jain

14

A study of the Natural Histoy of Leukocyte Chemotactic factor 2 Amyloidosis Disease

Medspace Clinical 沙巴体育 LLC

Dr Ravindra Prabhu

15

To Conduct a single centre cross sectional mixed-methods clinical needs assessment combining concurrent surveys with patients and providers with in-depth qualitative interviews with patients & providers

University of Chicago

Dr Shashikiran

16

Project – to provide a Palliative Care Training program aimed at developing Palliative Care services and making morphine supplies available at Cancer Treatment Centres (CTCs) in India

APHN-CTC

Dr Naveen Salins

17

Global Burden of Disease and Geospatial Analysis of Antimicrobial Resistance (GRAM)

University of Oxford

Dr Chiranjay Mukhopadhyay

18

VALIDATE Pump-Priming Grant: Characterizing the cellular immunity and metabolic response to Mycobacterium tuberculosis and Burkholderia pseudomallei in Indian patients for vaccine design

University of Oxford

Dr Chiranjay Mukhopadhyay

?

?